Department of Psychiatry, The Hospital for Sick Children, Toronto, Ontario, Canada.
Pediatrics. 2013 May;131(5):e1584-604. doi: 10.1542/peds.2012-0974. Epub 2013 Apr 1.
The US Agency for Healthcare Research and Quality sponsored a comparative effectiveness review of interventions for preschoolers at risk for attention-deficit/hyperactivity disorder (ADHD).
Medline, Cochrane CENTRAL, Embase, PsycInfo, and Education Resources Information Center were searched from 1980 to November 24, 2011. Selected studies were comparative, and enrolled children <6 years with clinically significant disruptive behavior, including ADHD. The interventions evaluated were parent behavior training (PBT), combined home and school/day care interventions, and methylphenidate use. Data were extracted by using customized software. Two independent raters evaluated studies as good, fair, or poor by using the Effective Public Health Practice Project Quality Assessment Tool for Quantitative Studies Risk of Bias. Overall strength of evidence (SOE) was rated for each intervention's effectiveness, accounting for study design, systematic error, consistency of results, directness of evidence, and certainty regarding outcome.
Fifty-five studies were examined. Only studies examining PBT interventions could be pooled statistically using meta-analysis. Eight "good" studies examined PBT, total n = 424; SOE was high for improved child behavior, standardized mean difference = -0.68 (95% confidence interval: -0.88 to -0.47), with minimal heterogeneity among studies. Only 1 good study evaluated methylphenidate, total n = 114; therefore, SOE for methylphenidate was low. Combined home and school/day care interventions showed inconsistent results. The literature reported adverse effects for methylphenidate but not for PBT.
With more studies consistently documenting effectiveness, PBT interventions have greater evidence of effectiveness than methylphenidate for treatment of preschoolers at risk for ADHD.
美国医疗保健研究与质量局对有注意力缺陷多动障碍(ADHD)风险的学龄前儿童的干预措施进行了一项比较效果评估。
从 1980 年至 2011 年 11 月 24 日,我们在 Medline、Cochrane 中心、Embase、PsycInfo 和教育资源信息中心进行了搜索。选择的研究是具有可比性的,纳入了有临床显著破坏性行为(包括 ADHD)的<6 岁儿童。评估的干预措施包括父母行为训练(PBT)、家庭和学校/日托综合干预以及使用哌醋甲酯。使用定制软件提取数据。两名独立评估员使用有效公共卫生实践项目质量评估工具(针对定量研究的风险偏倚)评估研究的质量,评估研究为“好”、“中”或“差”。根据研究设计、系统误差、结果一致性、证据直接性以及对结果的确定性,对每种干预措施的有效性进行了总体证据(SOE)评级。
共检查了 55 项研究。只有使用荟萃分析才能对评估 PBT 干预措施的研究进行统计学合并。有 8 项“好”的研究评估了 PBT,总样本量为 424 名儿童;儿童行为改善的 SOE 为高,标准化均数差=-0.68(95%置信区间:-0.88 至 -0.47),研究间异质性较小。只有 1 项“好”的研究评估了哌醋甲酯,总样本量为 114 名儿童;因此,哌醋甲酯的 SOE 较低。家庭和学校/日托综合干预措施的结果不一致。文献报道了哌醋甲酯的不良反应,但未报道 PBT 的不良反应。
随着更多研究一致地记录疗效,PBT 干预措施治疗有 ADHD 风险的学龄前儿童的疗效证据比哌醋甲酯更充分。